Advertisement Pharmaceutical Business review - Page 909 of 5274 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 20, 2026

QIAGEN and NVIDIA partner on AI drug discovery

QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.

Continue
Initial pilot programmes will be available to select pharmaceutical and biotechnology partners. Credit: Gorodenkoff / Shutterstock.com.
May 20, 2026

SERB signs agreement to acquire Idefirix rights for $133.6m

Idefirix desensitises adult kidney transplant patients with reactive IgG antibodies that could target donated tissues and increase rejection. Credit: sasirin pamai / Shutterstock.com.
May 19, 2026

VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain

VERTANICAL is undertaking a pivotal Phase III US trial for future FDA submission. Credit: Gorodenkoff / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates
  2. Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF
  3. FDA approves Enhertu for two HER2-positive early breast cancer indications
  4. Arna Pharma and Slate Run complete JV for new US company
  5. Kyowa Kirin secures FDA approval for Crysvita dosing update

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography